| Literature DB >> 27911804 |
Hanne Van Gorp1,2, Pedro H V Saavedra1,2, Nathalia M de Vasconcelos1,2, Nina Van Opdenbosch1,2, Lieselotte Vande Walle1,2, Magdalena Matusiak1,2, Giusi Prencipe3, Antonella Insalaco3, Filip Van Hauwermeiren1,2, Dieter Demon1,2, Delfien J Bogaert4,5,6, Melissa Dullaers4,7, Elfride De Baere8, Tino Hochepied1,9, Joke Dehoorne10, Karim Y Vermaelen2,11, Filomeen Haerynck4,5,6, Fabrizio De Benedetti3, Mohamed Lamkanfi12,2.
Abstract
Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease worldwide. It is caused by mutations in the inflammasome adaptor Pyrin, but how FMF mutations alter signaling in FMF patients is unknown. Herein, we establish Clostridium difficile and its enterotoxin A (TcdA) as Pyrin-activating agents and show that wild-type and FMF Pyrin are differentially controlled by microtubules. Diverse microtubule assembly inhibitors prevented Pyrin-mediated caspase-1 activation and secretion of IL-1β and IL-18 from mouse macrophages and human peripheral blood mononuclear cells (PBMCs). Remarkably, Pyrin inflammasome activation persisted upon microtubule disassembly in PBMCs of FMF patients but not in cells of patients afflicted with other autoinflammatory diseases. We further demonstrate that microtubules control Pyrin activation downstream of Pyrin dephosphorylation and that FMF mutations enable microtubule-independent assembly of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) micrometer-sized perinuclear structures (specks). The discovery that Pyrin mutations remove the obligatory requirement for microtubules in inflammasome activation provides a conceptual framework for understanding FMF and enables immunological screening of FMF mutations.Entities:
Keywords: FMF; Pyrin; colchicine; inflammasome; microtubules
Mesh:
Substances:
Year: 2016 PMID: 27911804 PMCID: PMC5167202 DOI: 10.1073/pnas.1613156113
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205